The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Newest first

New topics page 31

Topics ordered by when they were created rather than by activity. This is where a question that nobody has answered yet is easiest to find — and answering one is the fastest route to a first solution badge.

1,535 topics · page 31 of 40

TopicParticipantsRepliesViewsActivity
Coming back to: Resolution and tailing factor: real acceptance criteria
Posting this under the heading it deserves: Resolution and tailing factor: real acceptance criteria Everything below is what sits behind that. Posting the method first, because I know what the first three…
DOTMRLOAA+93 112 5.7k 9mo
[2026 update] What we do not know about retatrutide, listed explicitly
What we do not know about retatrutide, listed explicitly — that is the question, and I have not found it answered plainly anywhere I have looked. Comparing SCALE ( N Engl J Med , 2015) with STEP 2 ( Lancet ,…
FWCFATKCKB+79 83 952 11mo
Freeze-thaw and why one cycle is not the same as five — a second dataset
Freeze-thaw and why one cycle is not the same as five — a second dataset — setting out what I have, and where I think it stops being reliable. Practical question with the units stated, because I have seen how…
GOSAFNCAIA+47 55 46k 10mo
Adolescents: a distinct evidence base — one year on
Posting this under the heading it deserves: Adolescents: a distinct evidence base — one year on Everything below is what sits behind that. General question, not a request for advice about my own care — I know…
NIGHNCVEF+78 88 9.3k 3mo
Pooling trials with different estimands — what changed since
Pooling trials with different estimands — what changed since — setting out what I have, and where I think it stops being reliable. Comparing STEP 4 ( JAMA , 2021) with SURPASS-4 ( Lancet , 2021) and finding…
BERRMLDYAW+57 64 12k 7mo
Journal club: how we handle discontinuation in obesity trials
On the subject in the title: Journal club: how we handle discontinuation in obesity trials Working notes rather than a conclusion. Session topic: PIONEER 6 ( N Engl J Med , 2019). Please read it before…
LSCLPM 2 1.9k 12mo
Critiquing an observational claim about a class effect — one year on
Critiquing an observational claim about a class effect — one year on — setting out what I have, and where I think it stops being reliable. I have seen LEADER ( N Engl J Med , 2016) cited in support of a claim…
FELDKRAWDO+5 9 3.2k 8mo
Revisiting: Food effects on oral incretin absorption: what is documented
Revisiting: Food effects on oral incretin absorption: what is documented — setting out what I have, and where I think it stops being reliable. Session topic: SURMOUNT-2 ( Lancet , 2023). Please read it before…
CCIGTDAJEF+6 10 51k 13mo
Second pass at: Robustness: the parameters worth deliberately varying
On the subject in the title: Second pass at: Robustness: the parameters worth deliberately varying Working notes rather than a conclusion. I would like to understand what this number means before I repeat it…
BSFWDSCVOO+61 66 9.5k 3mo
[2026 update] Cold solution and stinging: the simplest fix
Cold solution and stinging: the simplest fix — setting out what I have, and where I think it stops being reliable. Reporting something rather than asking about it, in case the pattern is useful to anyone…
JDWPSAFNCA+6 10 496 11mo
Persistent vomiting and the threshold for seeking help
On the subject in the title: Persistent vomiting and the threshold for seeking help Working notes rather than a conclusion. General question, not a request for advice about my own care — I know the difference…
LCBAARLPP+82 88 31k 7mo
Pricing far outside the range, in either direction
Posting this under the heading it deserves: Pricing far outside the range, in either direction Everything below is what sits behind that. Structured report rather than an opinion, following the format the…
RLACBRSVTS+3 7 27k 7mo
About the Side effects category
Recognition, grading, timeline, and management. Adverse events that need urgent attention belong in Safety. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is…
BNDOFKITIL 4 7.1k 13mo
[2026 update] Scheduled maintenance and what will be unavailable
Posting this under the heading it deserves: Scheduled maintenance and what will be unavailable Everything below is what sits behind that. Process question about how this site works. I have read the guidelines…
TVSMNAHAKV+18 22 400 8mo
How to read a forest plot, properly, from scratch
The question in the title: How to read a forest plot, properly, from scratch I will give what I have already checked below so nobody repeats it. Session topic: STEP 4 ( JAMA , 2021). Please read it before…
SCPDBJRMYM+73 81 17k 7mo
Pages past their review date, listed
Pages past their review date, listed Writing it up because I had to work it out twice and would rather nobody else did. Nominating something for promotion into the documentation commons. The topic in question…
CLONKSHFF+26 30 6.4k 10mo
About the Dosing & titration category
Schedules, escalation intervals, dose reductions, and the arithmetic that connects a vial to a syringe mark. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is…
JMKILDNAW 4 350 4mo
"Greater than or equal to 99%" as a specification rather than a result
"Greater than or equal to 99%" as a specification rather than a result Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity arithmetic and I would…
MYJSRPTS+132 146 47k 5mo
Second pass at: Import rules for personal quantities, by jurisdiction, dated
Second pass at: Import rules for personal quantities, by jurisdiction, dated Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are…
DHKAV 2 5k 11mo
About the Administration category
Technique, needle selection, site rotation, injection discomfort, and what to do about a missed or partial dose. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit…
KDOJSLAR+5 9 3.1k 12mo
Comparing the STEP programme populations: who was actually enrolled — the long version
On the subject in the title: Comparing the STEP programme populations: who was actually enrolled — the long version Working notes rather than a conclusion. Comparing PIONEER 6 ( N Engl J Med , 2019) with…
ATMFEWSH 4 7.7k 11mo
Area percent versus weight percent: the confusion that causes most arguments — what changed since
Area percent versus weight percent: the confusion that causes most arguments — what changed since Writing it up because I had to work it out twice and would rather nobody else did. Posting the method first,…
VBSADMRLEN+30 34 40k 13mo
About the Tirzepatide category
Dual GIP/GLP-1 receptor agonist. SURPASS and SURMOUNT programme data, titration, and comparative discussion. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is…
SLTVDNSRM+2 6 132 13mo
Interim analyses and stopping rules — does this still hold?
Interim analyses and stopping rules — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Comparing SCALE ( N Engl J Med , 2015) with SURMOUNT-4 (…
JDMHKMFTHL+30 34 29k 13mo
AOD-9604 and the fragment hypothesis, revisited
Posting this under the heading it deserves: AOD-9604 and the fragment hypothesis, revisited Everything below is what sits behind that. Comparing SURPASS-2 ( N Engl J Med , 2021) with SUSTAIN 6 ( N Engl J Med…
ARCDJBMRBR+40 44 2.8k 6mo
Why a compound being unapproved is not the same as being illegal to possess
Why a compound being unapproved is not the same as being illegal to possess I have a specific reason for asking rather than idle curiosity, and the context is below. Structured report rather than an opinion,…
LCFNJBSCAN+72 78 23k 3mo
When to stop reading forums, including this one
When to stop reading forums, including this one I have a specific reason for asking rather than idle curiosity, and the context is below. General question, not a request for advice about my own care — I know…
CSTILFHKAA+78 86 47k 6mo
Coming back to: Why semaglutide solutions can look faintly opalescent and when that matters
Asking directly, because I could not find a straight answer: Why semaglutide solutions can look faintly opalescent and when that matters Comparing SELECT ( N Engl J Med , 2023) with PIONEER 6 ( N Engl J Med ,…
SZSFECRMMI+16 20 17k 13mo
How this community escalates rather than diagnoses
How this community escalates rather than diagnoses — that is the question, and I have not found it answered plainly anywhere I have looked. Asking about a population rather than about a person. The published…
BFOARNCHB 4 51k 8mo
Why semaglutide's albumin binding is the whole reason weekly dosing works
Asking directly, because I could not find a straight answer: Why semaglutide's albumin binding is the whole reason weekly dosing works Session topic: SELECT ( N Engl J Med , 2023). Please read it before…
MMLIYR 2 63k 5mo